×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
SESSION1-2: Early Phase and Regional Clinical Trials in Asia
Speaker(s)
Unique Strategy for Asian Oncology Development in an Early Phase by a Pharmaceutical Company
Morihiro Watanabe, MD, PhD
Merck Serono Co., Ltd., Japan
Head, Clinical Development Center, R&D Japan, North East Asia Hub
Early Clinical Trials in Korea
Yung-Jue Bang, MD, PhD
Seoul National University Hospital, Korea, Republic of
Professor, Internal Medicine
Have an account?